OTC Drug Trade Group: Monograph Reform Meetings With FDA Postponed

A leading trade association told Inside Health Policy that meetings with FDA regarding over-the-counter (OTC) monograph reform and user fees have been postponed as FDA and industry wait for officials within the Trump administration to take up their new roles. The statement from CHPA comes after an HHS spokesperson confirmed that separate user fee meetings with Congress were canceled to give President Donald Trump's administration time to meet with FDA staff. However, some congressional aides told IHP that no...